COPD, die dritthäufigste Todesursache weltweit, betrifft schätzungsweise 12,5 Millionen Menschen in den USA, führenden zu 150.000 Todesfälle pro Jahr.

The disease is also one of the most expensive chronic conditions, generating healthcare costs of over $30 billion per year in the US. Much of that cost is driven by exacerbations, the sudden and life-threatening deterioration in lung function experienced by COPD patients.

Exacerbation of chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) lead to high health care costs owing to increased emergency room (ER) visits and hospitalizations. Early interventions aim to improve the monitoring of symptoms to detect early deterioration and provide self-management strategies. The RE.ARZT COPD SDK can be added to any smartphone app to assist in the diagnosis and treatment support of COPD patients. Learn more at https://re.doctor/en/#COPD #copd #copdawareness